Duke Clinical Research Institute

Randomized, double blind, placebo-controlled, multicenter trial. Patients not on MRA at baseline were randomized to spironolactone 100 mg or placebo. Those on low-dose spironolactone (12.5 or 25 mg) were randomized to 100 mg spironolactone or 25 mg spironolactone for 96h

Uploaded by: Murkka Svensdottir
Filesize: 2 MB